A multi-centre, prospective, non-interventional, single-arm study investigating glycaemic control associated with the use of Dose Check app and insulin degludec in patients with type 2 diabetes mellitus in Saudi Arabia under real-world setting

Device

A multi-centre, prospective, non-interventional, single-arm study investigating glycaemic control associated with the use of Dose Check app and insulin degludec in patients with type 2 diabetes mellitus in Saudi Arabia under real-world setting


Protocol number

NN1250-7588


License Number

Novo Nordisk A/V


Status

Completed


Trial site

King Fahad Hospital of University, Al-Khobar